Pre-clinical combination of a PARP inhibitor, talazoparib, and carboplatin in triple-negative breast cancer.

被引：0

作者：

Cotte, Alexia ^{[1
]}

Beniey, Michele ^{[1
]}

Haque, Takrima ^{[2
]}

Bechir, Nelly ^{[2
]}

Hubert, Audrey ^{[1
]}

Diallo, Korotoum W. ^{[1
]}

Tran-Thanh, Danh ^{[2
]}

Hassan, Saima N. ^{[1
]}

机构：

[1] Univ Montreal, Ctr Rech Univ Montreal CRCHUM, Montreal, PQ H3C 3J7, Canada

[2] Ctr Rech Univ Montreal CRCHUM, Montreal, PQ, Canada

来源：

CANCER RESEARCH | 2021年 / 81卷 / 13期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1066

引用

页数：2

共 50 条

[41] In vitro cytotoxic effect of PARP inhibitor alone and in combination with nab-paclitaxel on triple-negative and luminal A breast cancer cells [J].

Topcul, Mehmet ;

Cetin, Idil ;

Turan, Suna Ozbas ;

Ozar, Melek Ozlem Kolusayin .

ONCOLOGY REPORTS, 2018, 40 (01) :527-535

[42] A multicentered randomized phase II comparison of single-agent carboplatin versus the combination of carboplatin and everolimus for the treatment of advanced triple-negative breast cancer. [J].

Fukui, Jami Aya ;

Shapiro, Charles L. ;

Ru, Meng ;

Klein, Paula ;

Fasano, Julie ;

Bhardwaj, Aarti ;

Irie, Hanna ;

Mandeli, John P. ;

Goel, Anupama ;

Kumarley, Neha ;

Gomes, Joni ;

Shuman, Nicholas ;

Francois, Damien ;

Tiersten, Amy .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)

[43] Dissecting the functional landscape of triple-negative breast cancer. [J].

Maxfield, Kimberly ;

Prat, Aleix ;

Corcoran, Kathleen ;

Whitehurst, Angelique .

CANCER RESEARCH, 2013, 73 (08)

[44] Preclinical studies with neratinib in triple-negative breast cancer. [J].

Mulloly, Maeve ;

O'Brien, Neil A. ;

Conklin, Dylan ;

Finn, Richard S. ;

Slamon, Dennis J. ;

Crown, John ;

O'Donovan, Norma ;

McGowan, Patricia M. ;

Duffy, Michael J. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)

[45] Sequential targeting of PARP with carboplatin inhibits primary tumour growth and distant metastasis in triple-negative breast cancer [J].

Beniey, Michele ;

Hubert, Audrey ;

Haque, Takrima ;

Cotte, Alexia Karen ;

Bechir, Nelly ;

Zhang, Xiaomeng ;

Tran-Thanh, Danh ;

Hassan, Saima .

BRITISH JOURNAL OF CANCER, 2023, 128 (10) :1964-1975

[46] Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer [J].

Wang, Dong ;

Du, Ruikai ;

Liu, Suling .

CHINESE JOURNAL OF CANCER, 2017, 36

[47] Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer [J].

Dong Wang ;

Ruikai Du ;

Suling Liu .

Chinese Journal of Cancer, 2017, 36 (06) :245-246

[48] Sequential targeting of PARP with carboplatin inhibits primary tumour growth and distant metastasis in triple-negative breast cancer [J].

Michèle Beniey ;

Audrey Hubert ;

Takrima Haque ;

Alexia Karen Cotte ;

Nelly Béchir ;

Xiaomeng Zhang ;

Danh Tran-Thanh ;

Saima Hassan .

British Journal of Cancer, 2023, 128 :1964-1975

[49] Association of statin use with clinical outcomes in patients with triple-negative breast cancer. [J].

Nowakowska, Malgorzata ;

Lei, Xiudong ;

Thompson, Mikayla R. ;

Shaitelman, Simona Flora ;

Wehner, Mackenzie ;

Woodward, Wendy A. ;

Giordano, Sharon H. ;

Nead, Kevin Thomas .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

[50] Novel synergistic combination therapies with BET bromodomain inhibitors in triple-negative breast cancer. [J].

Bevill, Samantha M. ;

Sciaky, Noah ;

Golitz, Brian T. ;

Rashid, Naim U. ;

Zawistowski, Jon S. ;

Johnson, Gary L. .

MOLECULAR CANCER RESEARCH, 2018, 16 (08) :80-80

← 1 2 3 4 5 →